Home LiteratureArticle Details
PMID: 1059108 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Properdin: initiation of alternative complement pathway.

Fearon DT, Austen KF

Abstract

Activation of the classical complement (C) system involves conversion of C1 to its active state with subsequent cleavage of C4 and -d C2 so as to form the classical C3 convertase, C42 (a bar indicates the activated form of a protein), which sequentially cleaves C3 and C5 to initiate the cytolytic event associated with the complete reaction. An alternative, pr properdin-dependent, pathway to complement activation generates a C3 convertase, C3B, that is formed by cleavage of B with D in the presence of a C3b, the major cleavage fragment of C3. C3b is capable of binding activated properidin (P) with resultant stabilization of C3B, which otherwise rapidly decays by loss of B activity. Initial cleavage of C3, a prerequisite for formation of C3B, is demonstrated to occur through the interaction of native C3 and B in the presence of either D or P alone, or together. The effect of P on the interaction of D, B, and C3 is attributed to stabilization of C3B as has been shown for C3B. Larger amounts of P and B with C3 in the absence of D form a C3 convertase that is designated (P)C3B to indicate that demonstrable cleavage of B does not occur although the active site is available. The generation of this initial convertase, as assessed by C3 inactivation, is dose-related to P and B inputs. The presence of both P and D greatly augments initial cleavage of C3 with D fully uncovering the active site of B and P stabilizing that site.

MeSH Terms
Complement C3/metabolism Complement System Proteins/metabolism Humans Immunoelectrophoresis Precipitin Tests Properdin/metabolism
Chemicals
Complement C3 Properdin Complement System Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fearon D T
Austen K F
References (22)
22 references, click to expand
  1. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
    Z Immun exp ther. 1959 Oct-Nov;118:349-57 PMID: 13801696
  2. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  3. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 May 1;121:819-33 PMID: 14280442
  4. Chromatographic resolution of the first component of human complement into three activities.
    J Exp Med. 1963 Jun 1;117:983-1008 PMID: 13929797
  5. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
    Science. 1954 Aug 20;120(3112):279-85 PMID: 13186838
  6. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  7. The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.
    J Exp Med. 1973 Aug 1;138(2):438-51 PMID: 4719679
  8. Glomerular and dermal depostion of properdin in systemic lupus erythematosus.
    N Engl J Med. 1972 Oct 5;287(14):681-5 PMID: 4115613
  9. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  10. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  11. A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.
    J Immunol. 1967 Dec;99(6):1162-72 PMID: 4168662
  12. Properties of highly purified human properdin.
    J Immunol. 1968 Jan;100(1):142-58 PMID: 4169693
  13. Some physical-chemical properties of chicken gamma-globulins and their pepsin and papain digestion products.
    Immunochemistry. 1966 Jan;3(1):11-20 PMID: 4161754
  14. Properdin factor D. II. Activation to D by properdin.
    J Exp Med. 1974 Aug 1;140(2):426-36 PMID: 4211020
  15. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
    J Exp Med. 1973 Dec 1;138(6):1305-13 PMID: 4202731
  16. Properdin factor D: characterization of its active site and isolation of the precursor form.
    J Exp Med. 1974 Feb 1;139(2):355-66 PMID: 4855753
  17. The role of properdin in the alternate pathway of complement activation.
    J Exp Med. 1974 Jan 1;139(1):44-57 PMID: 4808709
  18. Formation and function of a complex of the C3 proactivator with a protein from cobra venom.
    J Exp Med. 1973 Feb 1;137(2):451-60 PMID: 4734404
  19. The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
    J Exp Med. 1973 Feb 1;137(2):424-37 PMID: 4734403
  20. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).
    J Immunol. 1973 Jan;110(1):128-38 PMID: 4734384
  21. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    J Immunol. 1969 Mar;102(3):533-43 PMID: 5813010
  22. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    J Exp Med. 1967 Feb 1;125(2):359-80 PMID: 6019133
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1975-08-00
Pages
3220-4
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC432954
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com